The United Kingdom and European Union have reached different conclusions on whether talc should be classified as a carcinogen, creating regulatory divergence that complicates compliance for cosmetics manufacturers operating in both markets.
The Split
UK Position: Not Enough Evidence
The UK Health and Safety Executive (HSE) has declined to classify talc as a carcinogen under Great Britain’s Classification, Labeling, and Packaging rules. While acknowledging that talc poses lung toxicity risks, the HSE determined that insufficient evidence exists to support a cancer classification.
The HSE’s reasoning centers on a critical confounding factor: asbestos contamination has historically plagued talc products, making it difficult to isolate talc’s independent cancer risk.
As the HSE states: “Talc contaminated with even very small amounts of asbestos is considered to be carcinogenic.” This contamination history undermines the validity of epidemiological studies attempting to establish talc’s standalone risk.
EU Position: Category 1B Carcinogen
The European Chemicals Agency’s Risk Assessment Committee (RAC) reached the opposite conclusion, recommending that talc be classified as a Category 1B carcinogen: meaning it is “presumed to have carcinogenic potential for humans.”
The RAC cited:
- Evidence of lung tumors in animal studies
- Consistent occupational lung disease patterns
- A 20-30% increased ovarian cancer risk from genital talc use
| Jurisdiction | Classification | Basis |
|---|---|---|
| UK (HSE) | Not classified | Asbestos contamination confounds evidence |
| EU (RAC) | Category 1B (presumed carcinogen) | Animal studies + epidemiological data |
| IARC (2024) | Group 2A (probably carcinogenic) | Human evidence for ovarian cancer |
Under EU chemical classification, Category 1B means a substance is “presumed to have carcinogenic potential for humans” based largely on animal evidence. Category 1A is reserved for substances with confirmed human carcinogenicity.
The Contamination Question
Why This Matters
The core dispute hinges on whether talc itself causes cancer or whether the cancer risk comes from asbestos fibers that historically contaminated talc products.
This isn’t an academic distinction:
| If talc itself causes cancer | If only asbestos-contaminated talc causes cancer |
|---|---|
| All talc products pose risk | ”Asbestos-free” products may be safe |
| Classification is warranted | Classification may be overly broad |
| Industry-wide reformulation needed | Testing protocols are sufficient |
Industry Implications
The regulatory divergence creates compliance uncertainty. Manufacturers must now determine:
- Whether “asbestos-free” status can be reliably demonstrated
- How to label products for different markets
- Whether to reformulate products preemptively
The focus is shifting from debating talc’s hazard alone toward demonstrating product purity.
How We Got Here
IARC Classification (July 2024)
In July 2024, the World Health Organization’s International Agency for Research on Cancer (IARC) classified talc as Group 2A: probably carcinogenic to humans. This classification was based on:
- “Limited evidence” for cancer in humans (ovarian cancer)
- “Sufficient evidence” for cancer in experimental animals
The IARC classification influenced both the UK and EU reviews but didn’t determine their outcomes.
J&J Litigation Impact
The ongoing Johnson & Johnson talc litigation has generated extensive scientific debate. Juries in multiple trials have found that J&J’s talc products caused cancer, resulting in billions of dollars in verdicts.
| Recent Talc Verdicts | Amount |
|---|---|
| Craft v. J&J (Dec 2025) | $1.56 billion |
| Moore v. J&J (Oct 2025) | $966 million |
| Minnesota verdict (Dec 2025) | $65.5 million |
These verdicts reflect jury findings that asbestos-contaminated talc caused mesothelioma and ovarian cancer in specific plaintiffs.
What This Means for Consumers
Current Product Safety
Most major cosmetics companies have already moved away from talc:
- Johnson & Johnson discontinued talc-based baby powder globally in 2023
- Many cosmetics brands now use talc alternatives
- Products still containing talc are increasingly tested for asbestos
The Regulatory Landscape for Talc
The UK-EU split reflects a broader pattern of diverging safety standards since Brexit. Cosmetics companies that sell in both markets now face conflicting classification requirements, and the gap may widen further as each jurisdiction finalizes its rules.
In the United States, the regulatory picture remains unsettled. The FDA proposed a mandatory asbestos testing rule for talc cosmetics in 2022, then withdrew the proposal in late 2025. Meanwhile, courts have continued to find a connection between talc products and cancer, with juries awarding billions of dollars to people diagnosed with mesothelioma and ovarian cancer after long-term talc use.
Talc and asbestos form in the same geological deposits. Mining operations can introduce asbestos fibers into talc products, and this contamination has been documented in consumer products spanning decades. The question of whether talc itself, independent of asbestos contamination, causes cancer remains the central point of disagreement between UK and EU regulators.
Related Reading
- IARC Classifies Talc as Probably Carcinogenic
- J&J Talc Verdicts Exceed $2.5 Billion in 2025
- FDA Withdraws Talc Testing Rule
- Talcum Powder and Cancer Guide
Why did the UK and EU reach different conclusions about talc?▼
The two jurisdictions interpreted the same body of evidence differently. The UK Health and Safety Executive concluded that historical asbestos contamination in talc products confounds the epidemiological data, making it impossible to isolate talc’s independent cancer risk. The EU Risk Assessment Committee weighed animal studies and epidemiological data more heavily, concluding that the evidence supports classifying talc as a Category 1B presumed carcinogen.
What is IARC's classification of talc?▼
The International Agency for Research on Cancer (IARC) classified talc as Group 2A, meaning “probably carcinogenic to humans,” in July 2024. The classification was based on limited human evidence linking talc to ovarian cancer and sufficient evidence of carcinogenicity in animal studies.
Does 'asbestos-free' talc still pose a cancer risk?▼
This is the core dispute between UK and EU regulators. The EU’s Risk Assessment Committee says yes, recommending Category 1B classification for talc regardless of asbestos content. The UK’s Health and Safety Executive says the evidence is insufficient to draw that conclusion, arguing that asbestos contamination remains a confounding factor in the studies used to support classification.
How does this affect talc products currently on the market?▼
Most major companies have already moved away from talc. Johnson & Johnson discontinued its talc-based baby powder globally in 2023, and many cosmetics brands now use alternative ingredients. Products that still contain talc face increasing regulatory scrutiny, particularly in the EU market, where the Category 1B classification could lead to stricter labeling and formulation requirements.
References
Personal Care Insights. (2026). UK and EU split on cosmetic talc cancer risk as contamination clouds evidence.
https://www.personalcareinsights.com/news/uk-eu-talc-cancer-split.html